Results 101 to 110 of about 28,841 (163)

Eye‐Targeted A20 Gene Therapy Alleviates Ischemic Retinopathy by Reducing Pathologic Neovascularization, Gliosis, and Neuronal Apoptosis

The FASEB Journal, Volume 39, Issue 22, 30 November 2025.
Eye‐targeted A20 gene therapy alleviates ischemic retinopathy by limiting pathologic neovascularization, reducing gliosis, and protecting from neuronal apoptosis. ABSTRACT Intravitreal administration of anti‐VEGF therapies has been highly beneficial in treating ischemic proliferative retinopathies (PR).
Sanah Essayagh, Tarek Aridi, Tytteli Turunen, Lynn Choi, Hugo Adam, Nyah Patel, Salvatore T. Scali, Mark D. Fisher, Karl Skaf, Eva Csizmadia, Phillip Brennan, Anthony Sadek, Jona Skaf, Michelle Zhan, Emily Hansen, Maryam Shamloo, Nicholas R. DeStefino, Allen C. Clermont, Cleide Angolano, Christiane Ferran   +19 more
wiley   +1 more source

Role of internal limiting membrane peeling for cases of recalcitrant diabetic macular edema

Kerala Journal of Ophthalmology, 2017
Background/Aims: To investigate the efficacy of internal limiting membrane (ILM) peeling following pars plana vitrectomy for cases of recalcitrant diabetic macular edema in terms of improved visual acuity and reduced central macular thickness (CMT ...
Sujit Das, Rakesh Maggon
doaj   +1 more source

Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema

Clinical Ophthalmology, 2015
John Hall Alimera Sciences Ltd., Aldershot, Hampshire, UK I read “Dexamethasone intravitreal implant in the treatment of diabetic macular edema” published July 2015 by Dugel et al.1This article is very interesting in terms of providing an
Hall J
doaj  

A decade of SGLT2 inhibitors: Lessons learned and the road ahead in type 2 diabetes

Journal of Diabetes Investigation, EarlyView.
Tomohiko Kimura, Kohei Kaku
wiley   +1 more source

Retrospective Study of Diabetic Retinopathy and Macular Edema in Southern Part of Bangladesh

Journal of Ophthalmology
Background. Diabetic mellitus is a vision-threatening disease because it causes diabetic retinopathy worldwide. The main focus of this research is to determine the prevalence and assess the visual outcome in diabetic retinopathy and macular edema ...
Md. Asif Hasan, Sheikh Md. Rabiul Islam, Md. Arif Hayat Khan Pathan   +2 more
doaj   +1 more source

Turnover of Microaneurysms After Intravitreal Injections of Faricimab for Diabetic Macular Edema

, 2023
Yoshihiro Takamura, Yutaka Yamada, Masakazu Morioka, Makoto Gozawa, Takehiro Matsumura, Masaru Inatani   +5 more
openalex   +1 more source

Predictive Factors of Visual Outcome in Treatment-Naïve Diabetic Macular Edema: Preliminary Results from the Clinical Study “FOVEA” [PDF]

, 2023
Rita Serra, Florence Coscas, Jean François Boulet, Diogo Cabral, Thi Hà Châu Tran, Giuliana Solinas, Antonio Pinna, Marco Lupidi, G. Coscas   +8 more
openalex   +1 more source

Prevalence of diabetic macular edema among type II diabetic patients in tele-screening program using OCT and fundus photos in a tertiary hospital, Riyadh, Saudi Arabia

International Journal of Retina and Vitreous
Purpose To provide local data on the prevalence and risk factors of diabetic macular edema in the Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Abdullrahman Mohammed Alshehri, Mohammed Naji Almutairi, Mishari Alqahtani, Abdullmajeed Alfakhri   +3 more
doaj   +1 more source

Diabetic Macular Edema Characterization and Visualization Using Optical Coherence Tomography Images [PDF]

, 2020
Plácido L. Vidal, Joaquim de Moura, Macarena Díaz, Jorge Novo, Marcos Ortega   +4 more
openalex   +1 more source

Cystoid macular edema

Clinical Ophthalmology, 2008
Tryfon G Rotsos1, Marilita M Moschos21Medical Retina Service, Moorfields Eye Hospital, London, UK; 2Department of Ophthalmology, University of Athens, GreeceAbstract: We review the epidemiology, pathophysiology, and etiology of cystoid macular edema (CME)
Tryfon G Rotsos, Marilita M Moschos
doaj